Insider Buying: Prenetics Global (NASDAQ:PRE) CFO Buys 5,100 Shares

Prenetics Global Limited (NASDAQ:PRE) CFO Brian Rosin bought 5,100 shares of Prenetics Global stock in a transaction on Tuesday, August 25th. The shares were acquired at an average cost of $22.80 per share, for a total transaction of $116,280.00. Following the completion of the acquisition, the chief financial officer directly owned 23,100 shares in the company, valued at approximately $526,680. The trade was a 28.33% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

Prenetics Global Stock Performance

Shares of NASDAQ PRE opened at $23.25 on Wednesday. The stock has a market cap of $392.23 million, a P/E ratio of -5.59 and a beta of 0.26. Prenetics Global Limited has a 52-week low of $7.25 and a 52-week high of $23.63. The firm has a 50 day moving average price of $19.12 and a two-hundred day moving average price of $18.93.

Prenetics Global (NASDAQ:PRE) last issued its quarterly earnings results on Wednesday, August 19th. The company reported ($0.53) EPS for the quarter, beating analysts’ consensus estimates of ($0.84) by $0.31. Prenetics Global had a negative net margin of 47.43% and a negative return on equity of 21.41%. The business had revenue of $46.49 million for the quarter, compared to analysts’ expectations of $49.85 million. Analysts predict that Prenetics Global Limited will post -1.86 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Prenetics Global

A number of large investors have recently bought and sold shares of the stock. State of Wyoming acquired a new stake in shares of Prenetics Global in the 1st quarter valued at about $48,000. Wells Fargo & Company MN acquired a new position in Prenetics Global during the 4th quarter worth approximately $47,000. JPMorgan Chase & Co. bought a new position in Prenetics Global in the third quarter worth approximately $65,000. Operose Advisors LLC bought a new position in Prenetics Global in the second quarter worth approximately $129,000. Finally, Stevens Capital Partners grew its stake in Prenetics Global by 54.6% in the first quarter. Stevens Capital Partners now owns 28,147 shares of the company’s stock valued at $544,000 after acquiring an additional 9,940 shares during the period. 25.01% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities research analysts recently commented on PRE shares. Wall Street Zen upgraded Prenetics Global from a “sell” rating to a “hold” rating in a research report on Saturday. Weiss Ratings reissued a “sell (d-)” rating on shares of Prenetics Global in a research note on Friday, July 17th. Finally, Benchmark boosted their price target on Prenetics Global from $30.00 to $40.00 and gave the company a “buy” rating in a research note on Wednesday, July 15th. Four equities research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $34.25.

About Prenetics Global

Prenetics Global (NASDAQ: PRE) is a molecular diagnostics and genetic testing company that delivers a broad range of laboratory and at-home testing solutions. The company’s core offerings include next-generation sequencing (NGS) panels for hereditary health risks, pharmacogenomic reports to guide medication choices, and comprehensive consumer DNA testing services. In addition to genetic insights, Prenetics provides infectious disease diagnostics—most notably real-time PCR testing for pathogens such as SARS-CoV-2—through an integrated platform that combines sample collection, laboratory processing and digital reporting.

Serving both business-to-consumer and business-to-business markets, Prenetics operates a network of laboratories and service centers across Asia Pacific, Europe, the Middle East and North America.